Charles Schwab’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-17,190
| Closed | -$64K | – | 3570 |
|
|
2021
Q2 | $64K | Sell |
17,190
-15,217
| -47% | -$56.7K | ﹤0.01% | 3333 |
|
|
2021
Q1 | $113K | Sell |
32,407
-8,241
| -20% | -$28.7K | ﹤0.01% | 3372 |
|
|
2020
Q4 | $137K | Hold |
40,648
| – | – | ﹤0.01% | 3294 |
|
|
2020
Q3 | $143K | Hold |
40,648
| – | – | ﹤0.01% | 3223 |
|
|
2020
Q2 | $187K | Buy |
40,648
+3,849
| +10% | +$17.7K | ﹤0.01% | 3182 |
|
|
2020
Q1 | $122K | Hold |
36,799
| – | – | ﹤0.01% | 3089 |
|
|
2019
Q4 | $225K | Hold |
36,799
| – | – | ﹤0.01% | 3020 |
|
|
2019
Q3 | $154K | Hold |
36,799
| – | – | ﹤0.01% | 3071 |
|
|
2019
Q2 | $483K | Buy |
+36,799
| New | +$483K | ﹤0.01% | 2826 |
|